Origin of new drugs licensed or acquired, 2014-2018, by company size
Of the FDA approved drugs in the period 2014-2018, 71 percent that were licensed or acquired originated from a smaller biopharma company.
This statistic presents the percentage of origin of FDA-approved new drugs from 2014 to 2018 that were licensed or acquired, by company size.